AtriCure (ATRC) Operating Expenses (2010 - 2026)

AtriCure (ATRC) has reported Operating Expenses for 17 consecutive years, with $109.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 1.2% year-over-year to $109.0 million in Q2 2026; TTM through Jun 2026 was $421.7 million, a 3.46% increase from a year earlier, with the FY2025 full-year figure at $410.2 million, up 5.85% from the prior year.
• Operating Expenses was $109.0 million for Q2 2026 at AtriCure, roughly flat from $108.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $109.0 million in Q2 2026 and troughed at $69.2 million in Q4 2022.
• A 5-year average of $90.6 million and a median of $93.1 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 255.97% in 2022 and slipped 4.01% in 2025, its largest moves.
• Over 5 years, Operating Expenses stood at $69.2 million in 2022, then grew by 27.78% to $88.5 million in 2023, then grew by 21.09% to $107.1 million in 2024, then slipped by 4.01% to $102.8 million in 2025, then rose by 5.95% to $109.0 million in 2026.
• The last three Operating Expenses figures came in at $109.0 million (Q2 2026), $108.8 million (Q1 2026), and $102.8 million (Q4 2025), per Business Quant data.